You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

1,5-AG

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial in San Francisco (GlycoMark 1-5-AG, Clinical Performance and Value Vignettes)

Completed
Has Results
  • Diabetes
  • GlycoMark 1-5-AG
  • Clinical Performance and Value Vignettes
  • San Francisco, California
    QURE Healthcare
Oct 6, 2020

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)

Suspended
  • Recurrent Acute Myeloid Leukemia
  • Enasidenib Mesylate
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Los Angeles, California
  • +3 more
Sep 27, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Cobimetinib, Enasidenib Mesylate)

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Worldwide (AG-348)

Completed
Has Results
  • Pyruvate Kinase Deficiency
  • Anemia, Hemolytic
  • Oakland, California
  • +18 more
Dec 14, 2021

Integra® Cadence™ Total Ankle System in Primary Ankle Joint

Active, not recruiting
  • Degenerative Arthritis
  • +2 more
  • Implantation of Integra Cadence Total Ankle Sysyem
  • Gent, Belgium
  • +5 more
Nov 30, 2022

Tuberculosis Trial in Hamilton (Ad5Ag85A)

Completed
  • Tuberculosis
  • Ad5Ag85A
  • Hamilton, Ontario, Canada
    McMaster University Medical Centre
Oct 25, 2021

Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)

Active, not recruiting
  • Bioequivalence
  • Rivastigmine twice-weekly 9,5 mg/24 h
  • Exelon® 9.5 mg/24 h
  • Erfurt, Thuringia, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023

Hearing Loss, Auditory Perception, Music Therapy Trial in Toronto (Choir Singing, Music Appreciation)

Terminated
  • Hearing Loss
  • +3 more
  • Choir Singing
  • Music Appreciation
  • Toronto, Ontario, Canada
    Ryerson University
Dec 9, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Renal Cell Cancer Trial in Japan, United Kingdom, United States (Avelumab (MSB0010718C), Axitinib (AG-013736))

Completed
Has Results
  • Renal Cell Cancer
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Scottsdale, Arizona
  • +20 more
Dec 6, 2021

Lymphoma, B-Cell Trial in Vancouver, Toronto, Montreal (Venetoclax, RiTUXimab Injection, Rituximab SC)

Recruiting
  • Lymphoma, B-Cell
  • Vancouver, British Columbia, Canada
  • +2 more
Jan 24, 2022

Osteomyelitis, Prosthetic Joint Infection, Diabetic Foot Trial in Germany, Portugal, United Kingdom (Shorter Systemic

Recruiting
  • Osteomyelitis
  • +2 more
  • Shorter Systemic Antibiotics
  • Standard treatment
  • Regensburg, Germany
  • +22 more
Jan 30, 2023

Surgical Incision, Ulcer Foot, Ulcer Venous Trial in Germany, United Kingdom (PICO 14 single-use Negative Pressure Wound Therapy

Terminated
  • Surgical Incision
  • +5 more
  • PICO 14 single-use Negative Pressure Wound Therapy System
  • Stuttgart, Germany
  • +5 more
Oct 3, 2022

Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2021

Thalassemia Trial in Canada, United Kingdom, United States (AG-348)

Active, not recruiting
Has Results
  • Thalassemia
  • Oakland, California
  • +3 more
Jan 26, 2023

Advanced Solid Tumor Trial in Worldwide (RP-3500, Talazoparib, Gemcitabine Injection [Gemzar])

Recruiting
  • Advanced Solid Tumor
  • Chicago, Illinois
  • +12 more
Nov 18, 2022

Knee Injuries Trial in Poland, Spain, United Kingdom (dCELL® ACL Scaffold)

Completed
  • Knee Injuries
  • dCELL® ACL Scaffold
  • Zory, Ul. Bankowa 2, Poland
  • +7 more
Nov 24, 2022

Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

Recruiting
  • Mesothelioma, Malignant
  • Leicester, United Kingdom
    University Hospitals of Leicester NHS Trust
Apr 6, 2022

Diabetes Trial in Cairo (1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin ratio)

Recruiting
  • Diabetes Mellitus
  • 1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin ratio
  • Cairo, Manial, Egypt
    Cairo University
Mar 22, 2022

Maintenance Niraparib in Treatment of Ovarian CanceR

Recruiting
  • Ovarian Cancer
  • +2 more
  • Niraparib
  • Bath, United Kingdom
  • +14 more
Jan 5, 2022

Sepsis Trial in France (continuous pivotal ßL-AB, intermittent pivotal ßL-AB, AG infusion most 1 dose)

Not yet recruiting
  • Sepsis
  • continuous pivotal βL-AB
  • +3 more
  • Amiens, France
  • +23 more
Feb 1, 2023

Osteogenesis Imperfecta Trial in Ireland, United Kingdom (Teriparatide Pen Injector, Zoledronic Acid)

Recruiting
  • Osteogenesis Imperfecta
  • Teriparatide Pen Injector
  • Zoledronic Acid
  • Dublin, Ireland
  • +22 more
Mar 10, 2022

Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

Recruiting
  • Previously Untreated Acute Myeloid Leukemia
  • Samalizumab (BAML-16-001-S1)
  • +32 more
  • Phoenix, Arizona
  • +18 more
Oct 17, 2022